Removal of 10-hydroxycarbazepine by plasmapheresis

Therapeutic Drug Monitoring

Volumn 23, Issue 4, 2001, Pages 374-379

  Christensen, Jakob ^a,b   Balslev, Thomas ^b   Villadsen, Jan ^b   Heinsvig, Else Marie ^c   Dam, Mogens ^b   Poulsen, Jrgen H ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NONE

Author keywords

Oxcarbazepine; Plasmapheresis; Rasmussen encephalitis

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LICARBAZEPINE; NITRAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG METABOLISM; HUMAN; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RASMUSSEN SYNDROME; STEADY STATE; TREATMENT OUTCOME;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; HUMANS; MALE; PLASMAPHERESIS; TREATMENT OUTCOME;

EID: 0034896701     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200108000-00009     Document Type: Article

References (25)

1. Clinical studies of patients with focal epilepsy due to "chronic encephalitis"
2. Rasmussen's syndrome
3. Why would you remove half a brain? The outcome of 58 children after hemispherectomy - The Johns Hopkins experience: 1968 to 1996
4. Rasmussen's encephalitis: An autoimmune disorder?
5. Plasmapheresis in Rasmussen's encephalitis
6. Epilepsy, myasthenia gravis, and effect of plasmapheresis on antiepileptic drug concentrations
7. Removal of phenytoin by plasmapheresis in a patient with thrombotic thrombocytopenia purpura
8. Phenytoin and plasmapheresis: Importance of sampling times and impact of obesity
9. Evaluation of plasmapheresis in the treatment of an acute overdose of carbamazepine
10. Comparative pharmacokinetics of the newer antiepileptic drugs
11. Oxcarbazepine
12. Clinical pharmacology and pharmacokinetics of oxcarbazepine
13. Oxcarbazepine: Current status and clinical applications
14. Oxcarbazepine: A review
15. Oxcarbazepine
16. Therapeutic monitoring of the new antiepileptic drugs
17. Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects
18. GP47779, the main human metabolite of oxcarbazepine (Trileptal), and both enantiomers have equal anticonvulsant activity
19. Oxcarbazepine: Mechanisms of action
20. Use of saliva for monitoring oxcarbazepine therapy in epileptic patients
21. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations
22. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders
23. First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite